Nationwide Study Shows Resveratrol Impacts Alzheimer’s Biomarker

Nationwide Study Shows Resveratrol Impacts Alzheimer’s Biomarker
Results from the largest nationwide study investigating long-term high-dose resveratrol in patients with mild to moderate Alzheimer’s disease (AD) showed that a specific a biomarker that declines with disease progression was stabilized in patients who received resveratrol in its purified form. The results, published online in Neurology, “are very interesting,” according to the study’s principal investigator, R.

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *